Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester–AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors. 2015

Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye

Novel 3-hydroxy-3-phenylpropanoate ester-azidothymidine (AZT) conjugates have been prepared using Baylis-Hillman methodology, and their potential as dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors has been explored using enzyme inhibition and computer modelling techniques; their activity and HeLa cell toxicity have been compared with those of their cinnamate ester analogues.

UI MeSH Term Description Entries
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
May 2000, Journal of medicinal chemistry,
Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
April 2013, Bioorganic & medicinal chemistry,
Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
February 2008, Bioorganic & medicinal chemistry letters,
Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
May 1995, Journal of medicinal chemistry,
Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
April 2013, Yao xue xue bao = Acta pharmaceutica Sinica,
Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
April 2011, Bioorganic & medicinal chemistry letters,
Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
September 2003, Current medicinal chemistry,
Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
July 2007, Journal of medicinal chemistry,
Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
November 2016, Bioorganic & medicinal chemistry,
Meloddy H Manyeruke, and Temitope O Olomola, and Swarup Majumder, and Shaakira Abrahams, and Michelle Isaacs, and Nicodemus Mautsa, and Salerwe Mosebi, and Dumisani Mnkandhla, and Raymond Hewer, and Heinrich C Hoppe, and Rosalyn Klein, and Perry T Kaye
September 2019, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!